Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2101.85-40.2 (-1.88 % )
PREV CLOSE (Rs.) 2142.05
OPEN PRICE (Rs.) 2141.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5356
TODAY'S LOW / HIGH (Rs.)2084.15 2159.00
52 WK LOW / HIGH (Rs.)1768.55 2455.55
NSE2104.40 -37.9 (-1.77 % )
PREV CLOSE(Rs.) 2142.30
OPEN PRICE (Rs.) 2159.40
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 2104.40 (998 )
VOLUME 98862
TODAY'S LOW / HIGH(Rs.) 2084.00 2163.60
52 WK LOW / HIGH (Rs.)1749.9 2460

Company News

Date Heading Details
22-Jul-2021 Board Meeting Intimation for The Unaudited Financial Results Of The Company For The 1St Quarter Ended 30Th June, 2021 Of The Financial Year 2021-22. IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve the unaudited financial results of the Company for the 1st quarter ended 30th June, 2021 of the financial year 2021-22.
16-Jul-2021 Incorporation Of Section 8 Company By The Name 'Ipca Foundation' Incorporation of Section 8 Company by the name 'Ipca Foundation'
21-Jun-2021 Ipca Laboratories informs about disclosure of related party transactions <p align="justify">In accordance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ipca Laboratories has informed that it has enclosed the disclosure of related party transactions of the half year ended March 31, 2021.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
14-Jun-2021 Ashoka Buildcon, Ipca Laboratories and Reliance Industries to see some action today <p align="justify"><strong>Ashoka Buildcon</strong> has emerged as the lowest bidder (L-1) for project in Punjab. The company had submitted Bid to National Highways Authority of India (NHAl) in respect of the Project viz. 'Request for Proposal for Development of Memmadpur (Ambala) - Banur (IT City Chowk) -Kharar (Chandigarh) Corridor under Bharatmala Pariyojana - Package-II - 6 laning of IT City Chowk to Kurali Chandigarh Road (Design length: 31.23 Km) in the state of Punjab on EPC mode. The quoted value of the Project is Rs 726 crore.</p><p align="justify"><strong>Ipca Laboratories</strong> has acquired further 13.09% of the paid-up equity share capital of Trophic Wellness (TWPL), a company incorporated under the Companies Act, 1956 and engaged in the business of manufacturing and marketing several SKUs of Neutraceuticals underthe brand name ‘Nutricharge'. With this acquisition of these 13.09% of the equity share capital, the said Trophic Wellness has become a subsidiary of the Company. The Company now holds 52.35% of the paid-up equity share capital of TWPL.</p><p align="justify"><strong>Reliance Industries'</strong> (RIL) telecom arm -- Reliance Jio Infocomm (Jio) has introduced Jio Freedom plans, with five new ‘no daily limit' prepaid mobility offerings. The new plans listed on the website start from Rs 127 for 15 days validity, offering 12 GB of uncapped daily data over the plan period. Other plans with the validity of 30 days, 60 days, 90 days and 365 days have also been introduced. The five plans offer fixed data with no daily limit and unlimited voice.</p><p align="justify"><strong>ABB India</strong> has received approval from board of directors to divest/sale of Turbocharger business in Process Automation business segment and to divest/sale of Dodge Mechanical Power Transmission business in Motion business segment. In this regard, the Board authorized the management of the Company to take all required steps including appointment of advisors, valuers etc. </p><p align="justify"><strong>Info Edge's</strong> (India) board has approved acquisition of 100% of the Share Capital on a fully diluted basis of Zwayam Digital for an aggregate cash consideration of about Rs 61 crore. The proposed acquisition would help the company to further consolidate its position in the online recruitment solutions segment where its flagship brand Naukri.com already has an established leadership position. The Board of Directors of the company at its meeting held on June 11, 2021, has approved the same.</p><p align="justify"><strong>Axiscades Technologies</strong> has received approval from board for opening a wholly owned subsidiary in France. The company is opening owned subsidiary in order to have a separate legal entity to cater to the new business opportunities.The company shall keep the Exchanges apprised of all the material developments in this regard.</p><p align="justify"><strong>Welspun Corp</strong> is setting up a Greenfield facility at Anjar to enter the Ductile Iron (DI) Pipe business. Considering the expected demand, the company has decided to increase the capacity for DI Pipes to 400 KMTPA (from earlier proposed 250 KMPTA) and add DI Fittings to the product range. This would bring the total project cost to Rs 1,550 crore (plus soft cost) from the earlier planned Rs 1,250 crore (plus soft cost). The project is being funded through a combination of internal accruals and debt. There are no changes in the timelines and the project is expected to be commissioned by April 2022. As the project is currently under construction, there is no capacity utilization as of now.<br></p>
14-Jun-2021 Ipca Laboratories surges on acquiring additional 13.09% stake in Trophic Wellness <p align="justify">Ipca Laboratories is currently trading at Rs. 2065.40, up by 19.05 points or 0.93% from its previous closing of Rs. 2046.35 on the BSE.</p><p align="justify">The scrip opened at Rs. 2059.00 and has touched a high and low of Rs. 2065.40 and Rs. 2053.55 respectively. So far 651 shares were traded on the counter.</p><p align="justify">The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2455.55 on 28-Oct-2020 and a 52 week low of Rs. 1500.00 on 12-Jun-2020.</p><p align="justify">Last one week high and low of the scrip stood at Rs. 2063.00 and Rs. 2031.00 respectively. The current market cap of the company is Rs. 25958.38 crore.</p><p align="justify">The promoters holding in the company stood at 46.29%, while Institutions and Non-Institutions held 42.57% and 11.14% respectively.</p><p align="justify">Ipca Laboratories has acquired further 13.09% of the paid-up equity share capital of Trophic Wellness (TWPL), a company incorporated under the Companies Act, 1956 and engaged in the business of manufacturing and marketing several SKUs of Neutraceuticals underthe brand name ‘Nutricharge'.</p><p align="justify">With this acquisition of these 13.09% of the equity share capital, the said Trophic Wellness has become a subsidiary of the Company. The Company now holds 52.35% of the paid-up equity share capital of TWPL. </p><p align="justify">Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company's income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.<br></p>
14-Jun-2021 Announcement under Regulation 30 (LODR)-Acquisition Acquisition of further 13.09% of the paid-up equity share capital of M/s. Trophic Wellness Pvt. Ltd. (TWPL)
11-Jun-2021 Ipca Laboratories acquires additional 13.09% stake in Trophic Wellness <p align="justify">Ipca Laboratories has acquired further 13.09% of the paid-up equity share capital of Trophic Wellness (TWPL), a company incorporated under the Companies Act, 1956 and engaged in the business of manufacturing and marketing several SKUs of Neutraceuticals underthe brand name ‘Nutricharge'.<p align="justify">With this acquisition of these 13.09% of the equity share capital, the said Trophic Wellness has become a subsidiary of the Company. The Company now holds 52.35% of the paid-up equity share capital of TWPL. <p align="justify">Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company's income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.</p>
07-Jun-2021 Ipca Laboratories informs about analyst meet <p align="justify">Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that the Company is participating in the virtual group meetings of Analysts / Institutional Investors with its management: Organised by YES Securities India on Monday, 7th June, 2021 between 4.00 pm to 5.00 pm &amp; Organised by Investec Capital Services (India) on Tuesday, 8th June, 2021 between 2.00 pm to 4.30 pm. The virtual meetings, only publicly available information will be shared with the Analysts/institutional investors.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
02-Jun-2021 Ipca Laboratories informs about transcript of conference call <div align="justify"><span>Ipca Laboratories has informed that it enclosed transcript of Conference Call held on Monday, 31st May, 2021 at 11.00 hrs 1ST to discuss the Company's Q4FY21/ FY21 earnings and business update.</span></div><font face="sans-serif"><span><div align="justify"><br></div></span></font><div align="justify"><font face="sans-serif"><span>The above information is a part of company's filings submitted to BSE.</span></font></div>
27-May-2021 Ipca Laboratories informs about conference call <p align="justify">In accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that a conference call to discuss the company's Q4FY21/ FY21 earnings and business update will be held on Monday; 31st May, 2021 at 11.00 hrs IST. The company has enclosed the conference call/ Invite details.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>